Free Trial

Niagen Bioscience (NAGE) SEC Filings & 10K Form

Niagen Bioscience logo
$10.10 +0.37 (+3.80%)
As of 04:00 PM Eastern

Recent Niagen Bioscience SEC Filings

DateFilerForm TypeView
04/09/2025
6:52 PM
Fried Robert N (Reporting)
Niagen Bioscience, Inc. (Issuer)
Niagen Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:32 AM
Niagen Bioscience, Inc. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:11 AM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:17 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Fried Robert N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:18 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Pamir Ozan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:19 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:12 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Jaksch Frank L Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
12:54 PM
ChromaDex Corp. (Subject)
Niagen Bioscience (Subject)
Jaksch Frank L Jr (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
6:28 AM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Pamir Ozan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
4:20 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 424B3
11/21/2024
3:01 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:47 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Lopez Carlos Luis (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/31/2024
3:00 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
3:01 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
7:32 AM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
6:06 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Patrick Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
10:52 AM
ChromaDex Corp. (Subject)
Niagen Bioscience (Subject)
Patrick Kristin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
5:15 AM
Brilliant Dynasty Ltd (Reporting)
Champion River Ventures Ltd (Reporting)
Chau Hoi Shuen Solina Holly (Reporting)
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Dvorak International Ltd (Reporting)
Elgar International Ltd (Reporting)
Pioneer Step Holdings Ltd (Reporting)
Radiant Treasure Ltd (Reporting)
Skyinvest Associates Ltd (Reporting)
Winsave Resources Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:15 AM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Li Ka Shing (Reporting)
Mayspin Management Ltd (Reporting)
Prime Tech Global Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:05 AM
ChromaDex Corp. (Subject)
Niagen Bioscience (Subject)
Prime Tech Global Ltd (Filed by)
Form SC 13D/A
08/21/2024
5:06 AM
ChromaDex Corp. (Subject)
Niagen Bioscience (Subject)
Pioneer Step Holdings Ltd (Filed by)
Form SC 13D/A
08/07/2024
3:01 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:02 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:52 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Lee Jeong James (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2024
4:18 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:45 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Rubin Steven D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:42 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Shahbazi Hamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:43 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
YU Wing Tak Wendy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:43 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Ng Wang Yu Gary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:44 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Patrick Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:28 PM
ChromaDex Corp. (Filer)
Niagen Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
5:12 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Cohen Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
5:14 PM
ChromaDex Corp. (Issuer)
Niagen Bioscience (Issuer)
Jaksch Frank L Jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAGE) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners